T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21CIP1/WAF1 expression

Molecular and Cellular Biology

Volumn 23, Issue 2, 2003, Pages 566-578

  Huang, Zhi yong ^a   Wu, YanLi ^a   Hedrick, Nicolé ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; FIBRONECTIN; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL ADHESION; CELL AGGREGATION; CELL CYCLE G2 PHASE; CELL MOTILITY; CELL STRAIN; CONTROLLED STUDY; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GROWTH REGULATION; IN VITRO STUDY; MITOSIS INDEX; MITOSIS INHIBITION; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

ANEUPLOIDY; ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CADHERINS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; FIBROBLASTS; FLOW CYTOMETRY; G2 PHASE; MICE; MITOSIS; PROTEIN BIOSYNTHESIS; RATS; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037220234     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.2.566-578.2003     Document Type: Article

References (75)

1. Angst, B. D., C. Marcozzi, and A. I. Magee. 2001. The cadherin superfamily: Diversity in form and function. J. Cell Sci. 114:629-641.
2. Asano, K., O. Kubo, Y. Tajika, K. Takakura, and S. Suzuki. 2000. Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg. Rev. 23:39-44.
3. Asano, K., O. Kubo, Y. Tajika, M. C. Huang, K. Takakura, K. Ebina, and S. Suzuki. 1997. Expression and role of cadherins in astrocytic tumors. Brain Tumor Pathol. 14:27-33.
4. cip expression. J. Biol. Chem. 277:13761-13770.
5. Berx, G., and F. Van Roy. 2001. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 3:289-293.
6. Bremnes, R. M., R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin. 2002. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J. Clin. Oncol. 20:2417-2428.
7. Bulavin, D. V., Y. Higashimoto, I. J. Popoff, W. A. Gaarde, V. Basrur, O. Potapova, E. Appella, and A. J. Fornace, Jr. 2001. Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature 411:102-107.
8. Caskey, L. S., G. N. Fuller, J. M. Bruner, W. K. Yung, R. E. Sawaya, E. C. Holland, and W. Zhang. 2000. Toward a molecular classification of the gliomas: Histopathology, molecular genetics, and gene expression profiling. Histol. Histopathol. 15:971-981.
9. Cayrol, C., M. Knibiehler, and B. Ducommun. 1998. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells. Oncogene 16:311-320.
10. Chen, H., N. E. Paradies, M. Fedor-Chaiken, and R. Brackenbury. 1997. E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell Sci. 110:345-356.
11. KIP1. J. Cell Biol. 142:557-571.
12. Damiens, E., B. Baratte, D. Marie, G. Eisenbrand, and L. Meijer. 2001. Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: Induction of endoreplication following prophase arrest. Oncogene 20:3786-3797.
13. Datto, M. B., Y. Li, J. F. Panus, D. J. Howe, Y. Xiong, and X.-F. Wang. 1995. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 92:5545-5549.
14. Ding, H., L. Roncari, P. Shannon, X. Wu, N. Lau, J. Karaskova, D. H. Gutmann, J. A. Squire, A. Nagy, and A. Guha. 2001. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res. 61:3826-3836.
15. Dmitrieva, N. I., D. V. Bulavin, A. J. Fornace, Jr., and M. B. Burg. 2002. Rapid activation of G2/M checkpoint after hypertonic stress in renal inner medullary epithelial (IME) cells is protective and requires p38 kinase. Proc. Natl. Acad. Sci. USA 99:184-189.
16. Doyle, D. D., G. E. Goings, J. Upshaw-Earley, E. Page, B. Ranscht, and H. C. Palfrey. 1998. T-cadherin is a major glycophosphoinositol-anchored protein associated with noncaveolar detergent-insoluble domains of the cardiac sarcolemma. J. Biol. Chem. 273:6937-6943.
17. Cip1 at the onset of mitosis: A role at the G2/M-phase transition. Mol. Cell. Biol. 18:546-557.
18. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
19. WAF1/CIP1 and G2/M arrest. Mol. Endocrinol. 13:1738-1750.
20. Felsher, D. W., A. Zetterberg, J. Zhu, T. Tlsty, and J. M. Bishop. 2000. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc. Natl. Acad. Sci. USA 97:10544-10548.
21. Fredette, B. J., J. Miller, and B. Ranscht. 1996. Inhibition of motor axon growth by T-cadherin substrata. Development 122:3163-3171.
22. Gandarillas, A., D. Davies and J.-M. Blanchard. 2000, Normal and c-Mycpromoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication. Oncogene 19:3278-3289.
23. (WAF1/CIP1) gene. Exp. Cell Res. 246:280-289.
24. Giannakakou, P., R. Robey, T. Fojo, and M. V. Blagosklonny. 2001. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: Molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 20:3806-3813.
25. Gorospe, M., X. Wang, and N. J. Holbrook. 1999. Functional role of p21 during the cellular response to stress. Gene Expr. 7:377-385.
26. Gottardi, C. J., and B. M. Gumbiner. 2001. Adhesion signaling: How betacatenin interacts with its partners. Curr. Biol. 11:R792-R794.
27. Gutmann, D. H., A. Loehr, Y. Zhang, J. Kim, M. Henkemeyer, and A. Cashen. 1999. Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 18:4450-4459.
28. Gutmann, D. H., Z.-Y. Huang, N. M. Hedrick, H. Ding, A. Guha, and M. A. Watson. 2002. Mouse glioma gene expression profiling identifies novel human glioma-associated genes. Ann. Neurol. 51:393-405.
29. Handschuh, G., S. Candidus, B. Luber, U. Reich, C. Schott, S. Oswald, H. Becke, P. Hutzler, W. Birchmeier, H. Hofler, and K. F. Becker. 1999. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18:4301-4312.
30. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinase. Cell 75:805-816.
31. Hewett, S. J., D. W. Choi, and D. H. Gutmann. 1995. Expression of the neurofibromatosis 1 (NF1) gene in reactive astrocytes in vitro. Neuroreport 6:1565-1568.
32. Huang, Z.-Y., R. L. Baldwin, N. M. Hedrick, and D. H. Gutmann, 2002. Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivo. Oncogene 21:1325-1334.
33. Kemler, R. 1992. Classical cadherins. Semin. Cell Biol. 3:149-155.
34. Kinch, M. S., L. Petch, C. Zhong, and K. Burridge. 1997. E-cadherin engagement stimulates tyrosine phosphorylation. Cell Adhes. Commun. 4:425-437.
35. Kleihues, P., and W. K. Cavenee. 2000. Tumours of the Nervous System. IARC Press, Lyon, France.
36. Koller, E., and B. Ransch. 1996. Differential targeting of T-and N-cadherin in polarized epithelial cells. J. Biol. Chem. 271:30061-30067.
37. Kuzmenko, Y. S., F. Kern, V. N. Bochkov, V. A. Tkachuk, and T. J. Resink. 1998. Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: A function in negative regulation of smooth muscle cell growth? FEBS Lett. 434:183-187.
38. Lee, S. W. 1996. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat. Med. 2:776-782.
39. Lee, S. W., C. L. Reimer, D. B. Campbell, P. Cheresh, R. B. Duda, and O. Kocher. 1998. H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo. Carcinogenesis 19:1157-1159.
40. Levenberg, S., A. Yarden, Z. Kam, and B. Geiger. 1999. p27 is involved in N-cadherin-mediated contact inhibition of cell growth and S-phase entry. Oncogene 18:869-876.
41. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
42. Liu, Y., J. L. Martindale, M. Gorospe, and N. J. Holbrook. 1996. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56:31-35.
43. Minemoto, Y., J. Gannon, M. Masutani, H. Nakagama, T. Sasagawa, M. Inoue, Y. Masamune, and K. Yamashita. 2001. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53. Exp. Cell Res. 262:37-48.
44. Murai, T., Y. Nakagawa, H. Maeda, and K. Terada. 2001. Altered regulation of cell cycle machinery involved in interleukin-1-induced G1 and G2 phase growth arrest of A375S2 human melanoma cells. J. Biol. Chem. 276:67976806.
45. Nagafuchi, A., and M. Takeichi. 1988. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J. 7:3679-3684.
46. Neugebauer, K. M., K. J. Tomaselli, J. Lilien, and L. F. Reichardt. 1988. N-cadherin, NCAM, and integrins promote retinal neurite outgrowth on astrocytes in vitro. J. Cell Biol. 107:1177-1187.
47. 2/M cell cycle transition: pRb is a critical determinant in blocking DNA replication and in preventing endoduplication. Mol. Cell. Biol. 18:629-643.
48. Nieman, M. T., R. S. Prudoff, K. R. Johnson, and M. J. Wheelock. 1999. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 147:631-644.
49. 2+ binding site of uvomorulin abolish the adhesive function. Cell 63:1033-1038.
50. Philippova, M. P.,V. N. Bochkov, D. V. Stambolsky,V. A. Tkachuk, and T. J. Resink. 1998. T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett. 429:207-210.
51. Poon, R. Y., M. S. Chau, K. Yamashita, and T. Hunter. 1997. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res. 57:5168-5178.
52. Powell, S. N., J. S. DeFrank, P. Connell, M. Eogan, F. Preffer, D. Dombkowski, W. Tang, and S. Friend. 1995. Differential sensitivity of p53 (-) and p53 (+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55:1643-1648.
53. Ranscht, B., and M. T. Dours-Zimmermann. 1991. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron 7:391-402.
54. Resink, T. J., Y. S. Kuzmenko, F. Kern, D. Stambolsky, V. N. Bochkov, V. A. Tkachuk, P. Erne, and T. Niermann. 1999. LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions, FEBS Lett. 463:29-34.
55. Rigberg, D. A., T. A. Blinman, F. S. Kim, M. A. Cole, and D. W. McFadden. 1999. Antisense blockade of p21/WAF1 decreases radiation-induced G2 arrest in esophageal squamous cell carcinoma. J. Surg. Res. 81:6-10.
56. Cip1 degradation. J. Biol. Chem. 277:9684-9689.
57. Russell, K. J., L. W. Wiens, G. W. Demers, D. A. Galloway, S. E. Plon, and M. Groudine. 1995. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 55:1639-1642.
58. Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59:4375-4382.
59. Sasaki, C. Y., H. Lin, P. J. Morin, and D. L. Longo. 2000. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin. Cancer Res. 60:7057-7065.
60. Schnadelbach, O., O. W. Blaschuk, M. Symonds, B. J. Gour, P. Doherty, and J. W. Fawcett. 2000. N-cadherin influences migration of oligodendrocytes on astrocyte monolayers. Mol. Cell. Neurosci. 15:288-302.
61. Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
62. Shinoura, N., N. E. Paradies, R. E. Warnick, H. Chen, J. J. Larson, J. J. Tew, M. Simon, R. A. Lynch, Y. Kanai, S. Hirohashi, J. J. Hemperly, A. G. Menon, and R. Brackenbury. 1995. Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas. Br. J. Cancer 72:627-633.
63. Smits, V. A., R. Klompmaker, T. Vallenius, G. Rijksen, T. P. Makela, and R. H. Medema. 2000. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J. Biol. Chem. 275:30638-30643.
64. Takeichi, M. 1991. Cadherin cell adhesion receptor as a morphogenetic regulator. Science 251:1451-1455.
65. Takeuchi, T., A. Misaki, S.-B. Liang, A. Tachibana, N. Hayashi, H. Sonobe, and Y. Ohtsuki. 2000. Expression of T-cadherin (CDH13, H-cadherin) in human brain and its characteristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells. J. Neurochem. 74:1489-1497.
66. Takeuchi, T., and Y. Ohtsuki. 2001. Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol. Histopathol. 16:1287-1293.
67. Tomaselli, K. J., K. M. Neugebauer, J. L. Bixby, J. Lilien, L. F. Reichardt. 1988. N-cadherin and integrins: Two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces. Neuron 1:33-43.
68. Toyooka, K. O., S. Toyooka, A. K. Virmani, U. G. Sathyanarayana, D. M. Euhus, M. Gilcrease, J. D. Minna, and A. F. Gazdar. 2001. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas. Cancer Res. 61:4556-4560.
69. Vestal, D. J., and B. Ranscht. 1992. Glycosyl phosphatidylinositol-anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J. Cell Biol. 119:451-461.
70. Vleminckx, K., L. Vakaet, Jr., M. Mareel, W. Fiers, and F. van Roy. 1991. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119.
71. Wang, X., C. H. McGowan, M. Zhao, L. He, J. S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han. 2000. Involvement of the MKK-p38γ cascade in γ-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20:4543-4552.
72. cip1. Mol. Cell. Biol. 17:5598-5611.1997.
73. Yao, S. L., A. J. Akhtra, K. A. McKenna, G. C. Bedi, D. Sidransky, M. Mabry, R. Ravi, M. I. Collector, R. J. Jones, S. J. Sharskis, E. J. Fuchs, and A. Bedi. 1996. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat. Med. 2:1140-1143.
74. Zhong, Y., Y. Delgado, J. Gomez, S. W. Lee, and R. Perez-Soler. 2001. Loss of H-cadherin protein expression in human non-small cell lung cancer is associated with tumorigenicity. Clin. Cancer Res. 7:1683-1687.
75. Zhou, R., and O. Skalli. 2000. Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha. Differentiation 66:165-172.